“…Previously expressed and purified His tag recombinant EhLTP3 (rEhLTP3) and EhLTP1 (rEhLTP1) were used to study their abilities to bind with lipid molecules as per previously described protocol with slight modifications [57]. Briefly, each Membrane Lipid Strip (P-6002, Echelon Bioscience Inc.) where the following lipids were spotted: triglyceride (GT), diacylglycerol (DAG), phosphatidic Acid (PA), phosphatidylserine (PS), phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylglycerol (PG), cardiolipin (CL), phosphatidylinositol (PtdIns), PtdIns 4-phosphate [PI(4)P] (PtdIns phosphate called phosphoinositide, designated as PI), PtdIns 4,5-bisphosphate [PtdIns(4,5)P 2 ], PtdIns 3,4,5-trisphosphate [PtdIns (3,4,5)P 3 ], cholesterol, sphingomyelin (SM), 3-sulfogalactosylceramide or sulfatide (SGC), and Blue Blank; was blocked with 3% BSA in PBS for 2h at RT prior to incubation with either rEhLTP3 or rEhLTP1 (1mg/mL) in PBS with 3% BSA for 16 h at 4˚C.…”